300869 康泰医学
已收盘 11-06 15:00:00
资讯
新帖
简况
康泰医学获得实用新型专利授权：“可穿戴监护仪”
证券之星 · 11-06 04:07
康泰医学获得实用新型专利授权：“可穿戴监护仪”
康泰医学新注册《CMS50K腕式监测仪软件V1.0》项目的软件著作权
证券之星 · 11-05 05:42
康泰医学新注册《CMS50K腕式监测仪软件V1.0》项目的软件著作权
康泰医学连亏2年3季 IPO申万宏源保荐A股共募11亿元
中金财经 · 11-03
康泰医学连亏2年3季 IPO申万宏源保荐A股共募11亿元
康泰医学新注册《BC1000系列全自动生化分析仪分析软件V1.0》项目的软件著作权
证券之星 · 11-03
康泰医学新注册《BC1000系列全自动生化分析仪分析软件V1.0》项目的软件著作权
股市必读：康泰医学三季报 - 第三季度单季净利润同比下降6.32%
证券之星 · 11-02
股市必读：康泰医学三季报 - 第三季度单季净利润同比下降6.32%
康泰医学（300869）2026年三季报简析：增收不增利
证券之星 · 10-31
康泰医学（300869）2026年三季报简析：增收不增利
图解康泰医学三季报：第三季度单季净利润同比下降6.32%
证券之星 · 10-30
图解康泰医学三季报：第三季度单季净利润同比下降6.32%
康泰医学(300869.SZ)发布前三季度业绩，归母净亏损5728.25万元
智通财经 · 10-29
康泰医学(300869.SZ)发布前三季度业绩，归母净亏损5728.25万元
股市必读：康泰医学新发布《关于公司医疗器械注册证变更的公告》
证券之星 · 10-26
股市必读：康泰医学新发布《关于公司医疗器械注册证变更的公告》
康泰医学（300869）10月8日主力资金净买入14.89万元
证券之星 · 10-09
康泰医学（300869）10月8日主力资金净买入14.89万元
康泰医学（300869）披露全资子公司血糖监测系统获CE证书，9月28日股价下跌0.96%
证券之星 · 09-28
康泰医学（300869）披露全资子公司血糖监测系统获CE证书，9月28日股价下跌0.96%
康泰医学：9月16日召开业绩说明会，投资者参与
证券之星 · 09-17
康泰医学：9月16日召开业绩说明会，投资者参与
康泰医学（300869）披露设立长沙分公司公告，9月10日股价下跌1.89%
证券之星 · 09-10
康泰医学（300869）披露设立长沙分公司公告，9月10日股价下跌1.89%
股市必读：康泰医学中报 - 第二季度单季净利润同比下降8275.72%
证券之星 · 08-31
股市必读：康泰医学中报 - 第二季度单季净利润同比下降8275.72%
康泰医学（300869）2026年中报简析：增收不增利，三费占比上升明显
证券之星 · 08-29
康泰医学（300869）2026年中报简析：增收不增利，三费占比上升明显
康泰医学最新公告：血糖监测系统获得欧盟CE证书
证券之星 · 08-28
康泰医学最新公告：血糖监测系统获得欧盟CE证书
康泰医学连亏两年半 A股共募11亿IPO申万宏源保荐
中金财经 · 08-28
康泰医学连亏两年半 A股共募11亿IPO申万宏源保荐
股市必读：康泰医学新发布《第五届董事会第三次会议决议公告》
证券之星 · 08-28
股市必读：康泰医学新发布《第五届董事会第三次会议决议公告》
图解康泰医学中报：第二季度单季净利润同比下降8275.72%
证券之星 · 08-28
图解康泰医学中报：第二季度单季净利润同比下降8275.72%
康泰医学（300869）披露2026年半年度报告及其摘要，8月27日股价上涨0.52%
证券之星 · 08-27
康泰医学（300869）披露2026年半年度报告及其摘要，8月27日股价上涨0.52%
暂无数据
公司概况
公司名称：
康泰医学系统(秦皇岛)股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-08-24
主营业务：
康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。公司的主要产品是血氧类、心电类、超声类、监护类、血压类、分析测试类等多类产品以及数字化医疗健康服务。
发行价格：
10.16
{"stockData":{"symbol":"300869","market":"SZ","secType":"STK","nameCN":"康泰医学","latestPrice":9.96,"timestamp":1793948583000,"preClose":10.2,"halted":0,"volume":4351800,"delay":0,"changeRate":-0.0235,"floatShares":264000000,"shares":401999999,"eps":-0.2268,"marketStatus":"已收盘","change":-0.24,"latestTime":"11-06 15:00:00","open":10,"high":10.11,"low":9.9,"amount":43502400,"amplitude":0.0206,"askPrice":9.97,"askSize":88,"bidPrice":9.96,"bidSize":9,"shortable":0,"etf":0,"ttmEps":-0.2268,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":10.2,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":11.22,"lowLimit":9.18,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401804087,"isCdr":false,"pbRate":2.49,"roa":"--","roe":"--","epsLYR":-0.06,"committee":0.281009,"marketValue":4002000000,"turnoverRate":0.0165,"status":1,"floatMarketCap":2627000000},"requestUrl":"/m/hq/s/300869/tweets","defaultTab":"tweets","newsList":[{"id":"2681015750","title":"康泰医学获得实用新型专利授权：“可穿戴监护仪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2681015750","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681015750?lang=zh_cn&edition=full","pubTime":"2026-11-06 04:07","pubTimestamp":1793909249,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示康泰医学新获得一项实用新型专利授权，专利名为“可穿戴监护仪”，专利申请号为CN202522517207.2，授权日为2026年11月6日。本实用新型的可穿戴监护仪，通过将检测组件和电源组件集中安装在第一安装空间内，将控制组件安装在第二安装空间，能够使检测组件、电源组件和控制组件之间的连接走线更加方便，又能使整个壳体内的布局更加紧凑。今年以来康泰医学新获得专利授权31个，较去年同期减少了62.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600005220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681009533","title":"康泰医学新注册《CMS50K腕式监测仪软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2681009533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681009533?lang=zh_cn&edition=full","pubTime":"2026-11-05 05:42","pubTimestamp":1793828536,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康泰医学（300869）新注册了《CMS50K腕式监测仪软件V1.0》项目的软件著作权。今年以来康泰医学新注册软件著作权13个，较去年同期减少了88.98%。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了4475.73万元，同比减3.71%。通过天眼查大数据分析，康泰医学系统（秦皇岛）股份有限公司共对外投资了7家企业，参与招投标项目488次；财产线索方面有商标信息85条，专利信息676条，著作权信息455条；此外企业还拥有行政许可305个。数据来源：企查查以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500006575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680310745","title":"康泰医学连亏2年3季 IPO申万宏源保荐A股共募11亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680310745","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680310745?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:32","pubTimestamp":1793694732,"startTime":"0","endTime":"0","summary":"中国经济网北京11月3日讯 康泰医学 近日发布2026年第三季度报告。2026年前三季度，该公司实现营业收入3.54亿元，同比增长2.83%；归属于上市公司股东的净利为-5728.25万元，同比下降709.40%；归属于上市公司股东的扣除非经常性损益的净利润为-6851.51万元，同比下降1916.80%；经营活动产生的现金流量净额为764.22万元，同比下降61.01%。 康泰医学首次公开发行股票发行费用为4255.24万元，其中，保荐及承销费用2830.19万元。 经计算，康泰医学上市以来两次募资共11.17亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261103/32414570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["03130","06806","159982","BK1610","BK1147","REDS","82822","BK0028","82843","BK0188","KCE","83188","83130","399300","BK0012","BK0251","02846","BK1564","IPOS","BK0276","82846","FRHC","BK4127","02823","02827","300869","000166","03188","BK0183","07233","02822","82823","02843"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680799850","title":"康泰医学新注册《BC1000系列全自动生化分析仪分析软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2680799850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680799850?lang=zh_cn&edition=full","pubTime":"2026-11-03 06:10","pubTimestamp":1793657428,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康泰医学（300869）新注册了《BC1000系列全自动生化分析仪分析软件V1.0》项目的软件著作权。今年以来康泰医学新注册软件著作权12个，较去年同期减少了89.83%。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了4475.73万元，同比减3.71%。通过天眼查大数据分析，康泰医学系统（秦皇岛）股份有限公司共对外投资了7家企业，参与招投标项目488次；财产线索方面有商标信息85条，专利信息676条，著作权信息455条；此外企业还拥有行政许可305个。数据来源：企查查以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300007341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680789857","title":"股市必读：康泰医学三季报 - 第三季度单季净利润同比下降6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680789857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680789857?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:21","pubTimestamp":1793582519,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年三季度报告康泰医学2026年第三季度报告显示，本报告期营业收入为127,862,295.50元，比上年同期增长1.12%；归属于上市公司股东的净利润为-8,014,469.22元，比上年同期减少6.32%。经营活动产生的现金流量净额为7,642,193.91元，同比减少61.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200003657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679222497","title":"康泰医学（300869）2026年三季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2679222497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679222497?lang=zh_cn&edition=full","pubTime":"2026-10-31 11:55","pubTimestamp":1793418909,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期康泰医学发布2026年三季报。根据财报显示，康泰医学增收不增利。截至本报告期末，公司营业总收入3.54亿元，同比上升2.83%，归母净利润-5728.25万元，同比下降709.4%。本次财报公布的各项数据指标表现一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100025688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679724280","title":"图解康泰医学三季报：第三季度单季净利润同比下降6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679724280","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679724280?lang=zh_cn&edition=full","pubTime":"2026-10-30 02:16","pubTimestamp":1793297794,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学2026年三季报显示，前三季度公司主营收入3.54亿元，同比上升2.83%；归母净利润-5728.25万元，同比下降709.4%；扣非净利润-6851.51万元，同比下降1916.8%；其中2026年第三季度，公司单季度主营收入1.28亿元，同比上升1.12%；单季度归母净利润-801.45万元，同比下降6.32%；单季度扣非净利润-891.27万元，同比上升43.77%；负债率34.9%，投资收益885.85万元，财务费用3431.04万元，毛利率46.27%。财报数据概要请见下图:本文数据来源于康泰医学2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000004828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679407898","title":"康泰医学(300869.SZ)发布前三季度业绩，归母净亏损5728.25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679407898","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679407898?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:35","pubTimestamp":1793277316,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康泰医学(300869.SZ)发布2026年三季度报告，前三季度，公司实现营业收入3.54亿元，同比增长2.83%。归属于上市公司股东净亏损5728.25万元。归属于上市公司股东的扣除非经常性损益净亏损6851.51万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678412132","title":"股市必读：康泰医学新发布《关于公司医疗器械注册证变更的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678412132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678412132?lang=zh_cn&edition=full","pubTime":"2026-10-26 08:25","pubTimestamp":1792974312,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司获河北省药监局批准医用压缩式雾化器医疗器械变更注册，规格型号新增“NE-J02”，结构及组成、产品技术要求同步变更，批准日期为2026年9月17日。公司公告汇总关于公司医疗器械注册证变更的公告康泰医学系统（秦皇岛）股份有限公司近日收到河北省药品监督管理局颁发的《医疗器械变更注册文件》，产品名称为医用压缩式雾化器，注册证编号为冀械注准20232080181。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600002329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK1574","BK1583","300869","BK0251","159883","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674881765","title":"康泰医学（300869）10月8日主力资金净买入14.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674881765","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674881765?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:16","pubTimestamp":1791508582,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，康泰医学报收于10.76元，下跌5.2%，换手率3.54%，成交量9.34万手，成交额1.02亿元。近5日资金流向一览见下表：康泰医学融资融券信息显示，融资方面，当日融资买入696.24万元，融资偿还458.84万元，融资净买入237.4万元。康泰医学主营业务：医疗诊断、监护设备的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900007273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670125598","title":"康泰医学（300869）披露全资子公司血糖监测系统获CE证书，9月28日股价下跌0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670125598","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670125598?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:34","pubTimestamp":1790606063,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，康泰医学报收于11.35元，较前一交易日下跌0.96%，最新总市值为45.6亿元。该股当日开盘11.48元，最高11.6元，最低11.3元，成交额达3663.66万元，换手率为1.22%。康泰医学系统（秦皇岛）股份有限公司于近日发布《关于全资子公司产品获得CE证书的公告》。CE证书的取得表明产品符合欧盟相关要求，具备进入欧盟市场的准入条件。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668956339","title":"康泰医学：9月16日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2668956339","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668956339?lang=zh_cn&edition=full","pubTime":"2026-09-17 13:05","pubTimestamp":1789621513,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月17日康泰医学发布公告称公司于2026年9月16日召开业绩说明会。公司将持续与 FD 保持有效沟通，跟踪其书面审核结果及后续检查安排。同时，公司将做好接受后续检查的准备，争取尽早通过检查并解除警告。康泰医学主营业务：医疗诊断、监护设备的研发、生产和销售。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700016853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666629715","title":"康泰医学（300869）披露设立长沙分公司公告，9月10日股价下跌1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666629715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666629715?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:14","pubTimestamp":1789035253,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，康泰医学报收于10.92元，较前一交易日下跌1.89%，最新总市值为43.88亿元。近日，康泰医学系统（秦皇岛）股份有限公司披露《关于设立分公司的公告》。公告显示，公司于2026年9月7日召开第五届董事会第四次会议，审议通过设立长沙分公司的议案。分公司名称为康泰医学系统（秦皇岛）股份有限公司长沙分公司，类型为股份有限公司分公司，负责人为王树志。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000035034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663025542","title":"股市必读：康泰医学中报 - 第二季度单季净利润同比下降8275.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663025542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663025542?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:19","pubTimestamp":1788139188,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，康泰医学报收于11.25元，下跌3.02%，换手率1.97%，成交量5.2万手，成交额5864.39万元。业绩披露要点：2026年第二季度单季度归母净利润为-4102.62万元，同比下降8275.72%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100003509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016236","title":"康泰医学（300869）2026年中报简析：增收不增利，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016236","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016236?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:49","pubTimestamp":1787957358,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期康泰医学发布2026年中报。截至本报告期末，公司营业总收入2.26亿元，同比上升3.83%，归母净利润-4926.8万元，同比下降390.88%。本报告期康泰医学三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达59.2%。本次财报公布的各项数据指标表现一般。财报体检工具显示：建议关注公司债务状况本文数据来源于康泰医学2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900013074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662675510","title":"康泰医学最新公告：血糖监测系统获得欧盟CE证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2662675510","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662675510?lang=zh_cn&edition=full","pubTime":"2026-08-28 19:22","pubTimestamp":1787916140,"startTime":"0","endTime":"0","summary":"康泰医学(300869.SZ)公告称，公司近日取得TÜVSÜDProductServiceGmbH签发的CE证书，产品为血糖监测系统，包含血糖仪、血糖试纸条和血糖质控液，用于糖尿病控制效果监测。该证书表明产品符合欧盟要求，具备欧盟市场准入条件，将对公司未来经营产生积极影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800045179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FSXEmain","300869","FESXmain","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662057159","title":"康泰医学连亏两年半 A股共募11亿IPO申万宏源保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2662057159","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662057159?lang=zh_cn&edition=full","pubTime":"2026-08-28 15:59","pubTimestamp":1787903942,"startTime":"0","endTime":"0","summary":"中国经济网北京8月28日讯 康泰医学 昨日晚间发布的2026年半年度报告显示，报告期内，公司实现营业收入2.26亿元，同比增长3.83%；归属于上市公司股东的净利润-4926.80万元，上年同期为1693.76万元；归属于上市公司股东的扣除非经常性损益的净利润-5960.24万元，上年同期为1245.35万元；经营活动产生的现金流量净额为3343.99万元，同比增长29.13%。 经计算，康泰医学上市以来两次募资共11.17亿元。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/28/20260828751989.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/28/20260828751989.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260828/32351763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0276","83130","159982","BK1564","BK1147","000166","02827","82846","03130","IPOS","BK4127","FRHC","07233","BK0012","06806","399300","KCE","BK0183","BK0251","83188","02846","BK0188","BK0028","300869","REDS","03188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662303950","title":"股市必读：康泰医学新发布《第五届董事会第三次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662303950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662303950?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:28","pubTimestamp":1787869699,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，康泰医学报收于11.6元，上涨0.52%，换手率1.38%，成交量3.65万手，成交额4244.79万元。公司公告汇总第五届董事会第三次会议决议公告康泰医学系统（秦皇岛）股份有限公司于2026年8月26日召开第五届董事会第三次会议，审议通过《关于公司2026年半年度报告及其摘要的议案》《关于2026年半年度募集资金存放、管理与使用情况的专项报告的议案》《关于2026年半年度计提资产减值准备的议案》。所有议案均获全体董事一致通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662087482","title":"图解康泰医学中报：第二季度单季净利润同比下降8275.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662087482","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662087482?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:36","pubTimestamp":1787855770,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学2026年中报显示，上半年度公司主营收入2.26亿元，同比上升3.83%；归母净利润-4926.8万元，同比下降390.88%；扣非净利润-5960.24万元，同比下降578.6%；其中2026年第二季度，公司单季度主营收入1.26亿元，同比上升18.82%；单季度归母净利润-4102.62万元，同比下降8275.72%；单季度扣非净利润-4737.05万元，同比下降3499.12%；负债率36.24%，投资收益836.79万元，财务费用2487.09万元，毛利率48.45%。财报数据概要请见下图:本文数据来源于康泰医学2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800006010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662890086","title":"康泰医学（300869）披露2026年半年度报告及其摘要，8月27日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662890086","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662890086?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:27","pubTimestamp":1787840856,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，康泰医学报收于11.6元，较前一交易日上涨0.52%，最新总市值为46.61亿元。近日，康泰医学系统（秦皇岛）股份有限公司披露《第五届董事会第三次会议决议公告》。公告显示，公司于2026年8月26日召开第五届董事会第三次会议，审议通过《关于公司2026年半年度报告及其摘要的议案》《关于2026年半年度募集资金存放、管理与使用情况的专项报告的议案》《关于2026年半年度计提资产减值准备的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700055882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794069647684,"stockEarnings":[{"period":"1week","weight":0.0194},{"period":"1month","weight":-0.1225},{"period":"3month","weight":-0.1271},{"period":"6month","weight":-0.2374},{"period":"1year","weight":-0.3967},{"period":"ytd","weight":-0.336}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康泰医学系统(秦皇岛)股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"31121人(较上一季度增加4.68%)","perCapita":"8474股","listingDate":"2020-08-24","address":"河北省秦皇岛市海港区经济技术开发区秦皇西大街112号","registeredCapital":"40180万元","survey":" 康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。公司的主要产品是血氧类、心电类、超声类、监护类、血压类、分析测试类等多类产品以及数字化医疗健康服务。","listedPrice":10.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰医学,300869,康泰医学股票,康泰医学股票老虎,康泰医学股票老虎国际,康泰医学行情,康泰医学股票行情,康泰医学股价,康泰医学股市,康泰医学股票价格,康泰医学股票交易,康泰医学股票购买,康泰医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}